European Stocks Surge Amid U.S. Jobs Data and Healthcare Boost

Europe's benchmark stock index closed slightly higher on Thursday, supported by positive U.S. job market data and a recovery in the healthcare sector. Despite early losses primarily in technology stocks, key players like Novo Nordisk and several European insurers posted notable gains, offsetting broader market anxiety about potential U.S. recession signals.

Europe's benchmark stock index recouped early losses to close slightly higher on Thursday, buoyed by encouraging U.S. jobs market data and a boost from Novo Nordisk in the heavyweight healthcare sector.

The STOXX 600 ended the day 0.1% higher after suffering a sharp early decline in technology stocks, which had pushed the pan-European index down more than 1% intraday. Weekly U.S. jobless claims data revealed a drop exceeding expectations, easing fears of a significant weakening in the labour market and subsequent U.S. recession.

'Just because the labour market is cooling off doesn't mean we're entering a recession,' said Skyler Weinand, chief investment officer at Regan Capital. European stocks began to recover following the data, mirroring Wall Street's strong gains throughout the day. Investors are now awaiting German inflation data due on Friday for further clarity on Europe's economic outlook.

Europe's largest company by market value, Novo Nordisk, saw a 4.3% rise, recovering from a major drop the previous day. The healthcare sector was among the top gainers, bolstered further by an 8.3% jump in Hikma Pharmaceuticals. Media stocks lagged behind as the worst-hit sector.

Other key performers included Allianz, which gained 2% after a better-than-expected rise in second-quarter net profit, and Siemens, which rose 2.1% following strong quarterly earnings. In the telecom sector, Deutsche Telekom reported a notable increase in core earnings, while Entain in the gambling sector raised its annual revenue forecast.

However, valve maker Spirax-Sarco Engineering and sportswear maker Puma saw substantial declines after disappointing results and subsequent price-target cuts.